Technical Analysis for QGEN - Qiagen N.V.

Grade Last Price % Change Price Change
C 44.14 0.23% 0.10
QGEN closed up 0.23 percent on Monday, March 18, 2024, on 53 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
Earnings due: Mar 20
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Flat

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Cup with Handle Other 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
20 DMA Support Bullish 0.23%
50 DMA Support Bullish 0.23%
Pocket Pivot Bullish Swing Setup 0.23%
Cup with Handle Other 0.23%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 13 hours ago
10 DMA Resistance about 14 hours ago
Rose Above 10 DMA about 14 hours ago
60 Minute Opening Range Breakout about 15 hours ago
Rose Above Previous Day's High about 18 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Qiagen N.V. Description

QIAGEN N.V., through its subsidiaries, provides sample and assay technologies worldwide. It offers approximately 500 core consumable products, such as sample and assay kits, and automated instrumentation systems that empower customers to transform raw biological samples into molecular information. The company's consumable products are used for plasmid deoxyribonucleic acid (DNA) purification, and ribonucleic acid purification and stabilization; genomic and viral nucleic acid purification; nucleic acid transfection; polymerase chain reaction (PCR) amplification; reverse transcription; DNA cleanup after PCR and sequencing; and DNA cloning and protein purification. The company sells the digene HC2 HPV Test, a signal-amplified test for high-risk strains of the human papillomavirus. It also offers co-development services for companion diagnostics, technology licensing and patent sales services, and custom services, including whole genome amplification, DNA sequencing, and non-cGMP DNA production on a contract basis. The company's instrumentation systems automate the use of sample and assay technologies into solutions for a range of laboratory needs enabling customers to perform nucleic acid sample preparation, assay setup, target detection, and other laboratory tasks. Its automated systems include QIAsymphony, a modular system; Rotor-Gene Q, a rotary real-time PCR cycler system; PyroMark, a high-resolution detection platform based upon the Pyrosequencing technology; QIAcube, a sample processing instrument; QIAxcel for nucleic acid separation in low- to high-throughput laboratories; and ESE-Quant Tube Scanners, an optical measurement device. The company serves customer classes, including molecular diagnostics laboratories; applied testing customers in fields, such as forensics, veterinary diagnostics, and food safety; pharmaceutical research and development groups, and academic researchers. QIAGEN N.V. was founded in 1986 and is headquartered in Venlo, the Netherlands.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biology Acid Molecular Biology Lab Testing Scanner Molecular Diagnostics Food Safety Consumable Products Genome Transcription Cloning DNA Sequencing Laboratory Techniques Papillomavirus Companion Diagnostic Polymerase Chain Reaction Forensics HPV Instrumentation Systems Pharmaceutical Research Qiagen Real Time Polymerase Chain Reaction Technology Licensing

Is QGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 47.7479
52 Week Low 34.7749
Average Volume 1,196,426
200-Day Moving Average 42.96
50-Day Moving Average 44.03
20-Day Moving Average 43.83
10-Day Moving Average 44.31
Average True Range 0.67
RSI (14) 52.38
ADX 11.82
+DI 22.02
-DI 20.40
Chandelier Exit (Long, 3 ATRs) 43.07
Chandelier Exit (Short, 3 ATRs) 44.27
Upper Bollinger Bands 45.03
Lower Bollinger Band 42.62
Percent B (%b) 0.63
BandWidth 5.51
MACD Line 0.19
MACD Signal Line 0.16
MACD Histogram 0.0305
Fundamentals Value
Market Cap 9.77 Billion
Num Shares 221 Million
EPS 1.53
Price-to-Earnings (P/E) Ratio 28.85
Price-to-Sales 5.01
Price-to-Book 2.59
PEG Ratio 1.38
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.64
Resistance 3 (R3) 44.65 44.51 44.55
Resistance 2 (R2) 44.51 44.38 44.50 44.52
Resistance 1 (R1) 44.32 44.30 44.25 44.31 44.50
Pivot Point 44.18 44.18 44.14 44.17 44.18
Support 1 (S1) 43.99 44.05 43.92 43.98 43.78
Support 2 (S2) 43.85 43.97 43.84 43.76
Support 3 (S3) 43.66 43.85 43.73
Support 4 (S4) 43.65